Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

Dont Eat Me Hijacking of the 'Don't Eat Me' signal by Group B Streptococcus

Coordinator
Imperial College of Science Technology and Medicine, United Kingdom
Runs
1 August 2026 to 31 July 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101267450

What the project is doing

In the project's own words, from its summary on CORDIS.

Group B Streptococcus (GBS), or Streptococcus agalactiae, is the leading cause of sepsis and meningitis in human neonates and an emerging cause of invasive disease in adults. The detection of antibody-opsonised bacteria by phagocytic cells, like macrophages, elicits the ‘Eat Me’ signal that provides a critical arm of the host immune defence. Notably, bacterial pathogens often have immune evasion strategies to escape these processes.

However, not all immune evasion mechanisms are understood for GBS and bacterial pathogens. Since bacterial pathogens often target specific cellular receptors, the host lab has performed a novel high-throughput screening of 1500 human cellular receptors for their interaction with GBS to uncover new host-pathogen interactions. This analysis revealed that the top hit is an inhibitory receptor called SIRPα expressed on macrophages.

SIRPα detects CD47 on healthy cells to prevent macrophages from phagocytosing them. This is known as the ‘Don't Eat Me’ mechanism. Here, I hypothesise that bacterial pathogens like GBS interact with SIRPα to hijack the ‘Don’t Eat Me’ signal and evade macrophage phagocytosis and killing. I will use GBS as a study system. My objectives are to 1) use biochemical and structural approaches to define the GBS interaction with SIRPα, and use sophisticated genetic mutagenesis approaches to generate isogenic GBS strains that do not interact with SIRPα, 2) use cell and tissue infection models to determine the functional consequences of GBS targeting SIRPα.

Overall, I will uncover a novel immune evasion strategy of GBS and establish whether pathogenic bacteria hijack SIRPα for immune evasion. More broadly, I will establish for the first time that our new high-throughput screening approach can uncover novel bacteria-human receptor interactions that have functional consequences in bacterial infection biology.

Topics

Who is involved

OrganisationCityCountryRole
Imperial College of Science Technology and MedicineLondonUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI